Get the Stockscreener App
63.90
2.96%
-1.95
Pre-market:
63.56
-0.34
-0.53%
Netflix Inc stock is traded at $63.90, with a volume of 54.42M.
It is down -2.96% in the last 24 hours and down -10.18% over the past month.
Netflix's relatively simple business model involves only one business, its streaming service. It has the biggest television entertainment subscriber base in both the United States and the collective international market, with more than 300 million subscribers globally. Netflix has exposure to nearly the entire global population outside of China. The firm has traditionally avoided a regular slate of live programming or sports content, instead focusing on on-demand access to episodic television, movies, and documentaries. The firm introduced ad-supported subscription plans in 2022, giving the firm exposure to the advertising market in addition to the subscription fees that have historically accounted for nearly all its revenue.
See More
Previous Close:
$65.85
Open:
$65.16
24h Volume:
54.42M
Relative Volume:
1.08
Market Cap:
$266.08B
Revenue:
$48.77B
Net Income/Loss:
$13.65B
P/E Ratio:
20.13
EPS:
3.1742
Net Cash Flow:
$11.15B
1W Performance:
-6.97%
1M Performance:
-10.18%
6M Performance:
-30.06%
1Y Performance:
-41.62%
1-Day Range:
$0.00
$0.00
1-Week Range:
$62.86
$67.82
52-Week Range:
$62.86
$116.73
Netflix Inc Stock (NFLX) Company Profile
Name
Netflix Inc
Sector
Industry
Phone
408-540-3700
Address
121 ALBRIGHT WAY, LOS GATOS
Compare NFLX vs DIS, LYV, SKYD, FOXA
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NFLX
Netflix Inc
|
63.90 | 266.08B | 48.77B | 13.65B | 11.15B | 3.1742 |
DIS
Walt Disney Co
|
110.40 | 190.63B | 97.37B | 12.34B | 7.11B | 6.2499 |
LYV
Live Nation Entertainment Inc
|
172.58 | 40.20B | 25.61B | -229.57M | 1.21B | -1.7628 |
SKYD
Skydance Corporation
|
7.49 | 37.77B | 0 | 0 | 0 | 0.00 |
FOXA
Fox Corp
|
65.33 | 27.55B | 16.20B | 1.75B | 2.14B | 3.789 |
Netflix Inc Stock (NFLX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-22-26 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Oct-21-26 | Downgrade | Needham | Buy → Hold |
| Oct-15-26 | Resumed | Jefferies | Buy |
| Sep-29-26 | Upgrade | Deutsche Bank | Hold → Buy |
| Sep-22-26 | Downgrade | HSBC Securities | Buy → Hold |
| Sep-18-26 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Sep-14-26 | Reiterated | Evercore ISI | Outperform |
| Jul-13-26 | Reiterated | Oppenheimer | Outperform |
| Jul-08-26 | Reiterated | Bernstein | Outperform |
| Apr-27-26 | Downgrade | Erste Group | Buy → Hold |
| Apr-20-26 | Reiterated | Bernstein | Outperform |
| Apr-06-26 | Upgrade | Goldman | Neutral → Buy |
| Mar-30-26 | Initiated | Citizens | Mkt Perform |
| Mar-24-26 | Upgrade | Erste Group | Hold → Buy |
| Mar-18-26 | Resumed | Citigroup | Buy |
| Mar-09-26 | Resumed | Wells Fargo | Equal Weight |
| Mar-02-26 | Resumed | Barclays | Equal Weight |
| Mar-02-26 | Resumed | JP Morgan | Overweight |
| Feb-27-26 | Upgrade | Arete | Neutral → Buy |
| Feb-27-26 | Resumed | Evercore ISI | Outperform |
| Jan-23-26 | Reiterated | Robert W. Baird | Outperform |
| Jan-21-26 | Reiterated | BMO Capital Markets | Outperform |
| Jan-21-26 | Reiterated | Canaccord Genuity | Buy |
| Jan-21-26 | Reiterated | Deutsche Bank | Hold |
| Jan-21-26 | Reiterated | Goldman | Neutral |
| Jan-21-26 | Reiterated | Guggenheim | Buy |
| Jan-21-26 | Reiterated | KeyBanc Capital Markets | Overweight |
| Jan-21-26 | Reiterated | Morgan Stanley | Overweight |
| Jan-21-26 | Reiterated | Needham | Buy |
| Jan-21-26 | Reiterated | Oppenheimer | Outperform |
| Jan-21-26 | Reiterated | Piper Sandler | Overweight |
| Jan-21-26 | Reiterated | Pivotal Research Group | Hold |
| Jan-21-26 | Reiterated | Rosenblatt | Neutral |
| Jan-21-26 | Reiterated | Rothschild & Co Redburn | Buy |
| Jan-21-26 | Reiterated | TD Cowen | Buy |
| Jan-21-26 | Reiterated | UBS | Buy |
| Jan-21-26 | Reiterated | Wolfe Research | Outperform |
| Jan-12-26 | Initiated | HSBC Securities | Buy |
| Jan-09-26 | Reiterated | Goldman | Neutral |
| Dec-08-25 | Downgrade | Pivotal Research Group | Buy → Hold |
| Dec-08-25 | Downgrade | Rosenblatt | Buy → Neutral |
| Nov-18-25 | Reiterated | Barclays | Equal Weight |
| Oct-31-25 | Downgrade | Erste Group | Buy → Hold |
| Oct-07-25 | Upgrade | Seaport Research Partners | Neutral → Buy |
| Sep-17-25 | Upgrade | Loop Capital | Hold → Buy |
| Jul-10-25 | Reiterated | KeyBanc Capital Markets | Overweight |
| Jul-07-25 | Downgrade | Seaport Research Partners | Buy → Neutral |
| Jul-02-25 | Reiterated | Canaccord Genuity | Buy |
| Jul-02-25 | Reiterated | Goldman | Neutral |
| Jun-20-25 | Reiterated | Pivotal Research Group | Buy |
| Jun-12-25 | Reiterated | Oppenheimer | Outperform |
| Jun-03-25 | Reiterated | Jefferies | Buy |
| May-30-25 | Reiterated | BofA Securities | Buy |
| May-19-25 | Downgrade | JP Morgan | Overweight → Neutral |
| Apr-21-25 | Reiterated | BMO Capital Markets | Outperform |
| Apr-21-25 | Reiterated | Barclays | Equal Weight |
| Apr-21-25 | Reiterated | Canaccord Genuity | Buy |
| Apr-21-25 | Reiterated | Guggenheim | Buy |
| Apr-21-25 | Reiterated | JP Morgan | Overweight |
| Apr-21-25 | Reiterated | KeyBanc Capital Markets | Overweight |
| Apr-21-25 | Reiterated | MoffettNathanson | Buy |
| Apr-21-25 | Reiterated | Morgan Stanley | Overweight |
| Apr-21-25 | Reiterated | Oppenheimer | Outperform |
| Apr-21-25 | Reiterated | Piper Sandler | Overweight |
| Apr-21-25 | Reiterated | Pivotal Research Group | Buy |
| Apr-21-25 | Reiterated | Wells Fargo | Overweight |
| Apr-17-25 | Resumed | Piper Sandler | Overweight |
| Mar-27-25 | Initiated | FBN Securities | Outperform |
| Mar-17-25 | Upgrade | MoffettNathanson | Neutral → Buy |
| Jan-24-25 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Jan-23-25 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Jan-22-25 | Upgrade | Barclays | Underweight → Equal Weight |
| Jan-22-25 | Upgrade | Canaccord Genuity | Hold → Buy |
| Jan-22-25 | Reiterated | Oppenheimer | Outperform |
| Jan-22-25 | Reiterated | Pivotal Research Group | Buy |
| Jan-22-25 | Upgrade | Rosenblatt | Neutral → Buy |
| Jan-22-25 | Upgrade | The Benchmark Company | Sell → Hold |
| Jan-16-25 | Upgrade | Seaport Research Partners | Neutral → Buy |
| Jan-15-25 | Reiterated | BMO Capital Markets | Outperform |
| Jan-15-25 | Reiterated | Oppenheimer | Outperform |
| Jan-08-25 | Reiterated | Goldman | Neutral |
| Jan-06-25 | Reiterated | Argus | Buy |
| Jan-03-25 | Reiterated | The Benchmark Company | Sell |
| Dec-19-24 | Reiterated | UBS | Buy |
| Dec-16-24 | Downgrade | Loop Capital | Buy → Hold |
| Dec-16-24 | Reiterated | Oppenheimer | Outperform |
| Dec-11-24 | Reiterated | JP Morgan | Overweight |
| Nov-20-24 | Reiterated | Pivotal Research Group | Buy |
| Oct-18-24 | Reiterated | Needham | Buy |
| Oct-18-24 | Reiterated | Oppenheimer | Outperform |
| Oct-18-24 | Reiterated | Pivotal Research Group | Buy |
| Oct-16-24 | Reiterated | Loop Capital | Buy |
| Oct-11-24 | Reiterated | Guggenheim | Buy |
| Oct-10-24 | Reiterated | Morgan Stanley | Overweight |
| Oct-10-24 | Reiterated | Oppenheimer | Outperform |
| Oct-07-24 | Downgrade | Barclays | Equal Weight → Underweight |
| Oct-07-24 | Upgrade | Piper Sandler | Neutral → Overweight |
| Oct-01-24 | Reiterated | KeyBanc Capital Markets | Overweight |
| Sep-05-24 | Initiated | China Renaissance | Hold |
| Aug-30-24 | Reiterated | Pivotal Research Group | Buy |
| Jul-17-24 | Reiterated | Guggenheim | Buy |
| Jul-16-24 | Reiterated | The Benchmark Company | Sell |
| Jul-15-24 | Reiterated | BofA Securities | Buy |
| Jul-12-24 | Reiterated | JP Morgan | Overweight |
| Jul-10-24 | Reiterated | KeyBanc Capital Markets | Overweight |
| Jul-09-24 | Reiterated | TD Cowen | Buy |
| Jul-02-24 | Reiterated | Argus | Buy |
| May-28-24 | Reiterated | Evercore ISI | Outperform |
| Apr-19-24 | Downgrade | Canaccord Genuity | Buy → Hold |
| Apr-19-24 | Upgrade | Needham | Hold → Buy |
| Apr-19-24 | Reiterated | Pivotal Research Group | Buy |
| Apr-15-24 | Reiterated | Deutsche Bank | Hold |
| Apr-12-24 | Reiterated | Morgan Stanley | Overweight |
| Apr-12-24 | Reiterated | Piper Sandler | Neutral |
| Apr-05-24 | Reiterated | Pivotal Research Group | Buy |
| Mar-25-24 | Reiterated | Citigroup | Neutral |
| Mar-12-24 | Reiterated | Jefferies | Buy |
| Mar-11-24 | Reiterated | Oppenheimer | Outperform |
| Jan-30-24 | Downgrade | Seaport Research Partners | Buy → Neutral |
| Jan-25-24 | Upgrade | DZ Bank | Hold → Buy |
| Jan-24-24 | Reiterated | BMO Capital Markets | Outperform |
| Jan-24-24 | Reiterated | BofA Securities | Buy |
| Jan-24-24 | Reiterated | Canaccord Genuity | Buy |
| Jan-24-24 | Reiterated | Evercore ISI | Outperform |
| Jan-24-24 | Reiterated | Goldman | Neutral |
| Jan-24-24 | Reiterated | Guggenheim | Buy |
| Jan-24-24 | Reiterated | JP Morgan | Overweight |
| Jan-24-24 | Reiterated | KeyBanc Capital Markets | Overweight |
| Jan-24-24 | Upgrade | Macquarie | Neutral → Outperform |
| Jan-24-24 | Reiterated | Morgan Stanley | Overweight |
| Jan-24-24 | Reiterated | Oppenheimer | Outperform |
| Jan-24-24 | Reiterated | Piper Sandler | Neutral |
| Jan-24-24 | Reiterated | Pivotal Research Group | Buy |
| Jan-24-24 | Reiterated | Redburn Atlantic | Buy |
| Jan-24-24 | Reiterated | Robert W. Baird | Outperform |
| Jan-24-24 | Reiterated | TD Cowen | Outperform |
| Jan-24-24 | Reiterated | UBS | Buy |
| Jan-24-24 | Reiterated | Wells Fargo | Overweight |
| Sep-18-23 | Reiterated | Evercore ISI | Outperform |
| Aug-25-23 | Upgrade | Loop Capital | Hold → Buy |
| Jul-24-23 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Jul-17-23 | Reiterated | Deutsche Bank | Buy |
| Jul-13-23 | Reiterated | JP Morgan | Overweight |
| Jul-12-23 | Reiterated | UBS | Buy |
| Jul-05-23 | Upgrade | Goldman | Sell → Neutral |
| Jun-29-23 | Reiterated | Citigroup | Buy |
| Jun-28-23 | Reiterated | Oppenheimer | Outperform |
| Jun-13-23 | Reiterated | BofA Securities | Buy |
| Jun-13-23 | Reiterated | Guggenheim | Buy |
| Apr-19-23 | Reiterated | Deutsche Bank | Buy |
| Apr-19-23 | Reiterated | JP Morgan | Overweight |
| Apr-19-23 | Reiterated | Jefferies | Buy |
| Apr-19-23 | Reiterated | Piper Sandler | Neutral |
| Apr-19-23 | Reiterated | Pivotal Research Group | Buy |
| Apr-19-23 | Reiterated | Rosenblatt | Neutral |
| Apr-19-23 | Upgrade | UBS | Neutral → Buy |
| Apr-11-23 | Resumed | Robert W. Baird | Neutral |
| Jan-23-23 | Reiterated | Argus | Buy |
| Jan-20-23 | Reiterated | Canaccord Genuity | Buy |
| Jan-20-23 | Reiterated | Deutsche Bank | Buy |
| Jan-20-23 | Reiterated | Evercore ISI | Outperform |
| Jan-20-23 | Reiterated | Goldman | Sell |
| Jan-20-23 | Reiterated | Guggenheim | Buy |
| Jan-20-23 | Reiterated | Jefferies | Buy |
| Jan-20-23 | Reiterated | MoffettNathanson | Market Perform |
| Jan-20-23 | Reiterated | Oppenheimer | Outperform |
| Jan-20-23 | Reiterated | Piper Sandler | Neutral |
| Jan-20-23 | Reiterated | Pivotal Research Group | Buy |
| Jan-20-23 | Reiterated | Robert W. Baird | Neutral |
| Jan-20-23 | Reiterated | The Benchmark Company | Sell |
| Jan-20-23 | Reiterated | Wedbush | Outperform |
| Jan-20-23 | Reiterated | Wolfe Research | Outperform |
| Jan-12-23 | Upgrade | Jefferies | Hold → Buy |
| Jan-04-23 | Initiated | New Street | Neutral |
| Dec-29-22 | Upgrade | CFRA | Sell → Buy |
| Dec-14-22 | Reiterated | Jefferies | Hold |
| Dec-09-22 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jun-14-22 | Downgrade | The Benchmark Company | Hold → Sell |
| Jun-10-22 | Downgrade | Goldman | Neutral → Sell |
| May-16-22 | Upgrade | Wedbush | Neutral → Outperform |
| Apr-21-22 | Downgrade | DZ Bank | Buy → Hold |
| Apr-21-22 | Downgrade | Edward Jones | Buy → Hold |
| Apr-20-22 | Downgrade | Atlantic Equities | Overweight → Neutral |
| Apr-20-22 | Downgrade | BofA Securities | Buy → Underperform |
| Apr-20-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Apr-20-22 | Upgrade | Needham | Underperform → Hold |
| Apr-20-22 | Downgrade | Oppenheimer | Outperform → Perform |
| Apr-20-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Apr-20-22 | Downgrade | Pivotal Research Group | Buy → Sell |
| Apr-20-22 | Downgrade | Stifel | Buy → Hold |
| Apr-20-22 | Downgrade | UBS | Buy → Neutral |
| Apr-20-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-19-22 | Initiated | Rosenblatt | Neutral |
| Mar-09-22 | Upgrade | Wedbush | Underperform → Neutral |
| Jan-31-22 | Upgrade | Citigroup | Neutral → Buy |
| Jan-31-22 | Upgrade | Edward Jones | Hold → Buy |
| Jan-24-22 | Downgrade | Jefferies | Buy → Hold |
| Jan-21-22 | Reiterated | BMO Capital Markets | Outperform |
| Jan-21-22 | Reiterated | BofA Securities | Buy |
| Jan-21-22 | Reiterated | Canaccord Genuity | Buy |
| Jan-21-22 | Reiterated | Cowen | Outperform |
| Jan-21-22 | Reiterated | Deutsche Bank | Hold |
| Jan-21-22 | Reiterated | Goldman | Neutral |
| Jan-21-22 | Reiterated | Guggenheim | Buy |
| Jan-21-22 | Reiterated | JP Morgan | Overweight |
| Jan-21-22 | Reiterated | MoffettNathanson | Neutral |
| Jan-21-22 | Downgrade | Monness Crespi & Hardt | Buy → Neutral |
| Jan-21-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-21-22 | Reiterated | Oppenheimer | Outperform |
| Jan-21-22 | Reiterated | Piper Sandler | Overweight |
| Jan-21-22 | Reiterated | Pivotal Research Group | Buy |
| Jan-21-22 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Jan-21-22 | Reiterated | Stifel | Buy |
| Jan-21-22 | Upgrade | The Benchmark Company | Sell → Hold |
| Jan-21-22 | Downgrade | Truist | Buy → Hold |
| Jan-21-22 | Reiterated | UBS | Buy |
| Jan-21-22 | Reiterated | Wolfe Research | Outperform |
| Dec-15-21 | Reiterated | The Benchmark Company | Sell |
| Oct-20-21 | Downgrade | Deutsche Bank | Buy → Hold |
| Oct-20-21 | Reiterated | Monness Crespi & Hardt | Buy |
| Sep-29-21 | Reiterated | The Benchmark Company | Sell |
| Sep-13-21 | Initiated | Goldman | Neutral |
| Sep-08-21 | Reiterated | JP Morgan | Overweight |
| Sep-07-21 | Reiterated | Atlantic Equities | Overweight |
| Jul-21-21 | Reiterated | Credit Suisse | Outperform |
| Jul-21-21 | Reiterated | Deutsche Bank | Buy |
| Jul-21-21 | Reiterated | JP Morgan | Overweight |
| Jul-21-21 | Reiterated | KeyBanc Capital Markets | Overweight |
| Jul-21-21 | Reiterated | Stifel | Buy |
| Jun-25-21 | Upgrade | Credit Suisse | Neutral → Outperform |
| Jun-25-21 | Initiated | Edward Jones | Hold |
| May-19-21 | Resumed | Jefferies | Buy |
| Apr-21-21 | Resumed | Oppenheimer | Outperform |
| Apr-21-21 | Reiterated | Pivotal Research Group | Buy |
| Apr-21-21 | Upgrade | Stifel | Hold → Buy |
| Apr-06-21 | Resumed | Evercore ISI | Outperform |
| Apr-01-21 | Initiated | Piper Sandler | Overweight |
| Mar-25-21 | Reiterated | The Benchmark Company | Sell |
| Mar-23-21 | Upgrade | Argus | Hold → Buy |
| Jan-21-21 | Upgrade | DZ Bank | Hold → Buy |
| Jan-20-21 | Reiterated | Monness Crespi & Hardt | Buy |
| Jan-20-21 | Reiterated | Pivotal Research Group | Buy |
| Jan-20-21 | Reiterated | The Benchmark Company | Sell |
| Jan-20-21 | Upgrade | UBS | Neutral → Buy |
| Jan-20-21 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Oct-21-20 | Reiterated | BMO Capital Markets | Outperform |
| Oct-21-20 | Reiterated | Bernstein | Outperform |
| Oct-21-20 | Reiterated | Jefferies | Buy |
| Oct-21-20 | Reiterated | Morgan Stanley | Overweight |
| Oct-21-20 | Reiterated | Oppenheimer | Outperform |
| Oct-21-20 | Reiterated | Piper Sandler | Overweight |
| Oct-21-20 | Reiterated | Pivotal Research Group | Buy |
| Oct-21-20 | Reiterated | RBC Capital Mkts | Outperform |
| Oct-21-20 | Reiterated | The Benchmark Company | Sell |
| Oct-21-20 | Reiterated | Wedbush | Underperform |
| Oct-21-20 | Reiterated | Wells Fargo | Equal Weight |
| Oct-16-20 | Reiterated | Morgan Stanley | Overweight |
| Oct-15-20 | Reiterated | Canaccord Genuity | Buy |
| Oct-14-20 | Reiterated | Goldman | Buy |
| Oct-07-20 | Reiterated | Pivotal Research Group | Buy |
| Sep-28-20 | Reiterated | The Benchmark Company | Sell |
| Sep-15-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Sep-09-20 | Resumed | Raymond James | Mkt Perform |
| Sep-04-20 | Reiterated | The Benchmark Company | Sell |
| Jul-29-20 | Reiterated | Loop Capital | Buy |
View All
Netflix Inc Stock (NFLX) Latest News
Netflix Is Down 51% From Its High. History Suggests This Is What Happens Next. - The Motley Fool
Netflix Is Shaking Up Its Content Leadership. Here's What Needs to Happen Next. - The Motley Fool
Netflix Stock Has Always Overcome the Odds. Has It Finally Hit a Wall? - The Motley Fool
Can Netflix Stock Hold Margin Gains as Content Spending Keeps Growing? - Zacks Investment Research
Breakfast News: Week in Review - The Motley Fool
The 3rd Best Stock to Buy Right Now? - The Motley Fool
Stock Market Today, Oct. 22: Netflix Rises as Investors Capitalize on Post-Earnings Sell-Off - The Motley Fool
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought - The Motley Fool
Netflix Stock Is on Track for Its Worst Year Since 2022. Is It Finally a Buy? - The Motley Fool
Netflix Stock Is on Track for Its Worst Year Since 2022. Is It Finally a Buy? - The Motley Fool
MVP MMA On Netflix One And Done? - Yahoo Sports
Key facts: Netflix, Inc. Q3 $300M ad shortfall; banks cut targets - TradingView
Netflix: Sell-Off Creates A Buying Opportunity - Seeking Alpha
Netflix (NFLX) Stock Price Falls As Q3 Earnings Stir Valuation Doubts - Yahoo Finance
Netflix, Inc. Stock 12‑Month Price Target Cut to $86.41, Implies 26% Upside - TradingView
Why Netflix Stock Dropped Today - The Motley Fool
Stock Market Today, Oct. 21: Netflix Cuts Ad Revenue Guidance, Stock Slides 5% - The Motley Fool
Billionaire Bill Ackman Says Netflix Told Him 'We're Never Going to Do It' on Ads, Then Announced an Ad Model 'Literally 3 Weeks' Later Costing Him $400 Million - Barchart.com
Netflix Is Down 38% Since Completing Its 10-For-1 Stock Split. Here's Why the Sell-Off Is Worsening After Its Latest Earnings. - The Motley Fool
Skydance Trades at a Fraction of Netflix's Valuation. Is the Discount Deserved? - The Motley Fool
Netflix Just Reported a Record Quarter, 6 Days After Announcing It Was Laying Off 1,000 Employees - Inc.com
Netflix Jitters: Valid Concerns Or Market Overreaction? – “One Breakout Hit Could Shift Sentiment” - Deadline
More Live Sports Could Reverse Netflix’s Stock Slide - Sportico.com
Netflix, Inc. Stock 12‑Month Price Target Cut to $87.07, Implies 27% Upside - TradingView
No, I'm Not Selling You My Netflix Stock Today - The Motley Fool
No, I'm Not Selling You My Netflix Stock Today - The Motley Fool
Wall Street Lowers Netflix Stock Price Targets After Weak Outlook Overshadows Q3 Earnings - TheWrap
Netflix Stock Slammed With Price-Target Cuts After Q3 Report - Investor's Business Daily
Watch AT&T Falls on Earnings Miss; Netflix Reports Slowing Growth | Stock Movers - Bloomberg.com
Netflix (NFLX): Can Local-Language Hits Improve Returns on Content Spending? - Yahoo Finance
Netflix: 3 Key Takeaways for Long-Term Investors - The Motley Fool
Did SpaceX Just Save the AI Trade? - The Motley Fool
Buy the dip in Netflix stock as Q3 results show “no new negatives”: DB - Yahoo Finance
Netflix stock sinks as Wall Street lowers price targets following Q4 revenue forecast miss - Yahoo Finance
Netflix has 2 problems behind the stock slide — and they aren't YouTube, co-CEO Ted Sarandos says - Yahoo Finance
Netflix Stock Deflates to Two-Year Low. What Will It Take to Revive Revenue Growth? - Variety
Breakfast News: A $5.7 Billion Flex or Genius? - The Motley Fool
Netflix Q3 Earnings Beat Estimates, Ad Revenue View Trimmed - Zacks Investment Research
Netflix Stock and Price Targets Drop as Wall Street Debates If the Streamer Can Flip the Script - The Hollywood Reporter
Netflix Stock Drops. Why Wall Street Is Still Worried After Earnings Beat. - Barron's
Netflix Earnings: Growth Fears Are Real, but Shares Look Attractive - Morningstar
Don’t underestimate Netflix’s power to flip the script - Financial Times
Mature Business Means Slower Growth, but Netflix Remains the Clear Leader in Subscription Streaming - Morningstar
Netflix Inc (NFLX) (Q3 2026) Earnings Call Highlights: Ads Growth, Pricing Power and Content ... - Yahoo Finance
1 Reason Why Netflix Stock Looks Oversold - The Motley Fool
Netflix’s $300bn problem: lack of hits piles pressure on streaming giant - Financial Times
AMC Entertainment vs. Roblox: Which Media Stock Is a Better Buy in 2026? - The Motley Fool
Netflix Cut Its Ad Revenue Forecast by $300 Million. Does That Matter More Than Its Earnings Beat? - The Motley Fool
Netflix (NFLX) Reports Q3 Earnings: What Key Metrics Have to Say - Zacks Investment Research
Stock Market Today, Oct. 20: Netflix Q3 Revenue Rises 12% on Pricing Power - The Motley Fool
Netflix Inc Stock (NFLX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Netflix Inc Stock (NFLX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Richard Barton | Director |
Sep 10 '26 |
Proposed Sale |
75.27 |
720 |
54,194 |
0 |
| BARTON RICHARD N | Director |
Sep 10 '26 |
Option Exercise |
26.51 |
720 |
19,085 |
3,180 |
| BARTON RICHARD N | Director |
Sep 10 '26 |
Sale |
75.27 |
720 |
54,194 |
2,460 |
| Richard Barton | Director |
Sep 09 '26 |
Proposed Sale |
76.26 |
720 |
54,907 |
0 |
| BARTON RICHARD N | Director |
Sep 09 '26 |
Option Exercise |
24.46 |
720 |
17,613 |
3,180 |
| BARTON RICHARD N | Director |
Sep 09 '26 |
Sale |
76.26 |
720 |
54,907 |
2,460 |
| BARTON RICHARD N | Director |
Sep 08 '26 |
Option Exercise |
20.11 |
720 |
14,477 |
3,180 |
| BARTON RICHARD N | Director |
Sep 08 '26 |
Sale |
77.60 |
720 |
55,872 |
2,460 |
| Richard Barton | Director |
Sep 08 '26 |
Proposed Sale |
77.60 |
720 |
55,872 |
0 |
| Reed Hastings | Director |
Sep 01 '26 |
Proposed Sale |
80.95 |
311,300 |
25,198,860 |
0 |
1.88%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):